Metabolic implication of tigecycline as an efficacious second‐line treatment for sorafenib‐resistant hepatocellular carcinoma
暂无分享，去创建一个
A. Vollmar | H. Zischka | A. Gerbes | A. Koeberle | T. Fröhlich | A. Kiemer | S. Rothenfusser | G. Arnold | S. Schmitt | Martin Müller | J. Pachmayr | Lars M. Koenig | M. Meßner | H. Pein | M. Ardelt | P. Huber-Cantonati | Carina Ortler | Lena Zobel | Johanna Pachmayr